Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Jul;24(5):419–429. doi: 10.1136/jcp.24.5.419

Use and control of cephalosporins.

S Eykyn
PMCID: PMC477020  PMID: 4937134

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson R. M., Caisey J. D., Currie J. P., Middleton T. R., Pratt D. A., Sharpe H. M., Tomich E. G. Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol. 1966 May;8(3):407–428. doi: 10.1016/0041-008x(66)90051-2. [DOI] [PubMed] [Google Scholar]
  2. Atkinson R. M., Currie J. P., Davis B., Pratt D. A., Sharpe H. M., Tomich E. G. Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol. 1966 May;8(3):398–406. doi: 10.1016/0041-008x(66)90050-0. [DOI] [PubMed] [Google Scholar]
  3. Bailey R. R., Gower P. E., Dash C. H. The effect of impairment of renal function and haemodialysis on serum and urine levels of cephalexin. Postgrad Med J. 1970 Oct;(Suppl):60–64. [PubMed] [Google Scholar]
  4. Curtis J. R., Marshall M. J. Cephaloridine serum levels in patients on maintenance haemodialysis. Br Med J. 1970 Apr 18;2(5702):149–151. doi: 10.1136/bmj.2.5702.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fass R. J., Perkins R. L., Saslow S. Positive direct Coombs' tests associated with cephaloridine therapy. JAMA. 1970 Jul 6;213(1):121–123. [PubMed] [Google Scholar]
  6. Gralnick H. R., Wright L. D., Jr, McGinniss M. H. Coombs' positive reactions associated with sodium cephalothin therapy. JAMA. 1967 Mar 6;199(10):725–726. [PubMed] [Google Scholar]
  7. Kabins S. A., Kelner B., Walton E., Goldstein E. Cephalexin therapy as related to renal function. Am J Med Sci. 1970 Feb;259(2):133–142. doi: 10.1097/00000441-197002000-00007. [DOI] [PubMed] [Google Scholar]
  8. Kind A. C., Kestle D. G., Standiford H. C., Freeman P., Kirby W. M. Development of staphylococci cross-resistant to cephalexin and methicillin. Antimicrob Agents Chemother (Bethesda) 1968;8:405–409. [PubMed] [Google Scholar]
  9. Kind A. C., Kestle D. G., Standiford H. C., Kirby W. M. Laboratory and clinical experience with cephalexin. Antimicrob Agents Chemother (Bethesda) 1968;8:361–365. [PubMed] [Google Scholar]
  10. Kunin C. M., Atuk N. Excretion of cephaloridine and cephalothin in patients with renal impairment. N Engl J Med. 1966 Mar 24;274(12):654–656. doi: 10.1056/NEJM196603242741205. [DOI] [PubMed] [Google Scholar]
  11. Lawson D. H., Macadam R. F., Singh H., Gavras H., Linton A. L. The nephrotoxicity of cephaloridine. Postgrad Med J. 1970 Oct;(Suppl):36–39. [PubMed] [Google Scholar]
  12. Leigh D. A., Faiers M. C., Brumfitt W. Laboratory and clinical studies with cephalexin. Postgrad Med J. 1970 Oct;(Suppl):69–74. [PubMed] [Google Scholar]
  13. Molthan L., Reidenberg M. M., Eichman M. F. Positive direct Coombs tests due to cephalothin. N Engl J Med. 1967 Jul 20;277(3):123–125. doi: 10.1056/NEJM196707202770303. [DOI] [PubMed] [Google Scholar]
  14. Perkins R. L., Apicella M. A., Lee I. S., Cuppage F. E., Saslaw S. Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity. J Lab Clin Med. 1968 Jan;71(1):75–84. [PubMed] [Google Scholar]
  15. Pickering M. J., Spooner G. R., de Quesada A., Cade J. R. Declining renal function associated with administration of cephalothin. South Med J. 1970 Apr;63(4):426–428. doi: 10.1097/00007611-197004000-00020. [DOI] [PubMed] [Google Scholar]
  16. Rahal J. J., Jr, Meyers B. R., Weinstein L. Treatment of bacterial endocarditis with cephalothin. N Engl J Med. 1968 Dec 12;279(24):1305–1309. doi: 10.1056/NEJM196812122792403. [DOI] [PubMed] [Google Scholar]
  17. Turcotte J. G., Herrmann T. J., Haig O., O'Dell C., Jr, Cerny J., Greene J. A., Jr Oliguria following transplantation of kidneys donated by blood relatives. Surg Gynecol Obstet. 1970 Jan;130(1):29–36. [PubMed] [Google Scholar]
  18. Weinstein L., Kaplan K. The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection. Ann Intern Med. 1970 May;72(5):729–739. doi: 10.7326/0003-4819-72-5-729. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES